T-Mobile US, Inc.

TMUSL

Held by 3 specialist biotech funds

High Convergence

3 funds opened new positions.

Telecommunications ServicesCEO: Srinivasan GopalanIPO: 2025Website ↗

T-Mobile USA, Inc. engages in the provision of wireless voice, messaging, and data services. It offers different plans for phones and tablets. The company was founded by John W. Stanton in 1994 and is headquartered in Bellevue, WA.

BiotechEdge

Catalysts Conferences Companies Convergence Fund Insiders Signals Squeeze Cash Runway Research Weekly Briefs 13F Changes Glossary PricingSign In Start 14-Day Free Trial

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

Feedback

Score Holdings Short Interest Catalysts Insiders Research

Signal Score

4.3/10

3 funds opened new positions●●

No recent insider activity●●

No upcoming catalysts●●

Held by 3 specialist funds●●

See how each signal contributes — fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

3 fund convergence

Driehaus Capital

Deerfield Management

Tang Capital Management

Position history (shares)

Tang Capital Management

AI Signal

Signal Note: Driehaus Capital Exits T-Mobile US

Driehaus Capital's exit from T-Mobile US (TMUSL) appears to be a portfolio rebalancing decision unrelated to biotech fundamentals—T-Mobile is a telecom operator with no drug development pipeline. This exit likely reflects Driehaus's shift in capital allocation away from non-core holdings rather than a biotech-specific thesis change.

Unlock full AI analysis — 14-day free trial

4 quarters